WOODHOUSE DAVID J — SEC Form 4 filings

SEC reporting owner CIK 1642995. 5 Form 4 filings on record with FilingPulse; latest filed 2026-05-14.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-18 to 2026-05-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NGM BIOPHARMACEUTICALS INC (NGM)Chief Executive Officer, Director214
Surrozen, Inc./DE (SRZN)Director33

Form 4 filings — WOODHOUSE DAVID J

FiledFormIssuerReported transactionsSource
2026-05-144Surrozen, Inc./DE (SRZN)Grant/award (A): 5,550 (derivative) @ $0EDGAR
2025-05-154Surrozen, Inc./DE (SRZN)Grant/award (A): 1,333 (derivative) @ $0EDGAR
2024-06-064Surrozen, Inc./DE (SRZN)Grant/award (A): 1,333 (derivative) @ $0EDGAR
2024-04-084NGM BIOPHARMACEUTICALS INC (NGM)Code (U): 23,993 · Code (U): 97,654 · Disposition to issuer (D): 95,400 (derivative) · Disposition to issuer (D): 255,000 (derivative) · Disposition to issuer (D): 87,013 (derivative) · Disposition to issuer (D): 57,833 (derivative) · +7 moreEDGAR
2024-01-184NGM BIOPHARMACEUTICALS INC (NGM)Tax withholding (F): 13,032 @ $1.34EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1642995 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →